[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346572-105":59,"doc-detail-346572-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-model-for-pulmonary-metastasis-in-patients-with-her2-positive-breast-cancer-a-population-based-study","Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study","","Lung metastasis is a key adverse prognostic factor in HER2-positive breast cancer, yet accurate estimation of outcomes for patients with pulmonary metastasis remains limited. This population-based study develops and validates a nomogram using the SEER database to identify prognostic factors for lung metastasis and to estimate individualized survival. The model provides survival predictions at 6 months, 1 year, and 2 years, with performance assessed using discrimination and calibration metrics.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-model-for-pulmonary-metastasis-in-patients-with-her2-positive-breast-cancer-a-population-based-study/346572/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-model-for-pulmonary-metastasis-in-patients-with-her2-positive-breast-cancer-a-population-based-study/346572.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What population and data source were used to build the prognostic model?","Question",{"text":112,"@type":113},"The study included 613 HER2-positive breast cancer patients with lung metastasis from the SEER database, split into training and test groups.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the nomogram constructed and evaluated?",{"text":117,"@type":113},"Univariate and multivariate Cox regression analyses were used to identify prognostic variables, then a nomogram predicted survival at 6 months, 1 year, and 2 years. Performance was assessed with C-index and calibration plots.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with better overall survival?",{"text":121,"@type":113},"Surgical resection of the primary tumor and chemotherapy were significantly associated with improved overall survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346572,1790144073,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Breast Cancer (2026) 33:544–556  \n[https://doi.org/10.1007/s12282-026-01836-5](https://doi.org/10.1007/s12282-026-01836-5)  \nORIGINAL ARTICLE  \nPrognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study  \nJun Pang1 · Bingbing Huang1 · Wanying Yan1 · Huijun He1 · Nvzhu Liao1 · Wenna Sun1 · Yaoquan Li1 · Lishan Luo1 · Wei Zeng1  \nReceived: 2 October 2025 / Accepted: 3 February 2026 / Published online: 16 February 2026 © The Author(s) 2026  \nAbstract  \nBackground Lung metastasis is an important adverse prognostic factor in patients with HER2-positive breast cancer. However, a lack of an accurate estimation of the prognosis of patients with lung metastasis and the validation of population-based models has been observed. In this study, we aimed to establish a nomogram based on the surveillance, epidemiology, and end results (SEER) database to determine the prognostic factors associated with lung metastasis and evaluate the individualized survival of patients with lung metastasis.  \nMethods This study included 613 patients diagnosed with HER2-positive breast cancer with lung metastasis (HER2 + BC-LM) from the SEER database and randomly divided them into two groups: (1) training group (n= 432) and (2) test group (n= 181) . Based on the univariate and multivariate Cox regression analyses, we assessed the impact of multiple variables on the survival ofthe patients in the training group and constructed a nomogram to predict the survival probabilities of the patients at 6 months, 1 year, and 2 years. Furthermore, the nomogram was validated by the concordance index (C-index) and calibration plots.  \nResults A prognostic model for predicting the prognosis of patients with HER2 + BC-LM was established and validated. For the patients diagnosed with HER2 + BC-LM, the C-index (0.813 in the training group and 0.787 in the validation group, respectively) and calibration plots revealed that the prognostic accuracy and clinical applicability of the nomogram were acceptable. The surgical resection of the primary tumor and chemotherapy were found to be significantly associated with better overall survival (OS) .  \nConclusion A sensitive and discriminatory model was established to predict the OS of patients with HER2 + BC-LM.  \nKeywords HER2-positive breast cancer · Lung metastasis · SEER database · Nomogram · Prognosis  \nIntroduction  \nAccording to the latest estimates of the International Agency for Research on Cancer, female breast cancer will be the second leading cause of global cancer incidence in 2022, with an estimated 2.3 million new cases, accounting for 11.6% of all cancer cases. Among women, breast cancer has become the most common cancer and a major cause of  \nJun Pang and Bingbing Huang have contributed equally to this work.  \n􀀍 Wei Zeng [ZW13250111008@outlook.com](ZW13250111008@outlook.com)  \n1 Department of Breast Surgery,Shunde Women and Children’s Hospital, Guangdong Medical University, Foshan  \n528300, China  \ncancer deaths worldwide [1] . In 2024, 310,720 newly diagnosed cases of breast cancer and 42,250 deaths due to breast cancer in the United States were recorded [2]. In fact, nearly 90% of breast cancer-related deaths are caused by metastatic diseases rather than the primary tumor [3] . Common distant metastatic sites of breast cancer include the bones, lungs, liver, and brain.  \nEpidemiological studies tend to classify the subtypes of breast cancer as luminal A (ER-or PR-positive and HER2-negative), luminal B (ER-or PR-positive and HER2-positive), triple-negative (ER-, PR-, and HER2-negative), and HER2-overexpressing (ER- and PR-negative and HER2-positive) [4] . As a type of breast cancer subtype, HER2-positive breast cancer refers to the type of breast cancer in which the epidermal growth factor receptor (HER2) with tyrosine kinase activity is overexpressed in breast cancer  \ncells [5] . HER2-positive breast cancer is characterized by a strong invasiveness and high metast","cbCain8ZzKQVcyBU","https://ap.wps.com/l/cbCain8ZzKQVcyBU","pdf",2682672,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What population and data source were used to build the prognostic model?\",\"answer\":\"The study included 613 HER2-positive breast cancer patients with lung metastasis from the SEER database, split into training and test groups.\"},{\"question\":\"How was the nomogram constructed and evaluated?\",\"answer\":\"Univariate and multivariate Cox regression analyses were used to identify prognostic variables, then a nomogram predicted survival at 6 months, 1 year, and 2 years. Performance was assessed with C-index and calibration plots.\"},{\"question\":\"Which factors were associated with better overall survival?\",\"answer\":\"Surgical resection of the primary tumor and chemotherapy were significantly associated with improved overall survival.\"}]","Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study | PDF",1790062005,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47214b353b3b11646b910b578d8c2c0c.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cebf6454e8c41e5b65fca739f5342db9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98769430de968dab1f83e835372355f7.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e72a515f80e153167d22a154e509a58.webp",980,1301]